CARS logo

Data-Powered Strategies to Counteract Antibiotic Resistance

The emergence of antibiotic resistance in bacterial pathogens is a considerable threat to the way we practice medicine. Patients currently experience significant delays in diagnosing drug resistance, and by the time the resistance is recognized patients may have already suffered considerable disability. Even when it is recognized often the therapies that clinicians can offer are much more limited or have unfavorable side effect profiles.

This symposium brings together thought leaders from academic to industry pursuing innovative strategies driven by large scale data such as genomics, transcriptomics, phenomics, health-services databases or internet and social media sources. Their common goals are the prevision use and development of antibiotics to counter drug resistance. The day is organized into three main thematic areas focusing on diagnostics, big data, and therapeutics.